CL
Colgate-PalmolivePrevious close
95.29
Change
+2.13 / +2.29%
P/E (TTM) ?
38.1
Market Cap
$76.6B
1M
+11.69%
S&P 500 −0.91% over same period
Volume / Avg Volume
8.8M / 4.4M
2.00× average
Latest earnings analysisFY2026 Q2Reported 2026-07-31
Colgate Q2 2026: organic sales +2.4%, gross margin 61.5%, GAAP EPS $0.86
Colgate's second quarter of 2026 was a split decision: the base business beat and gross margin expanded 140 basis points, but GAAP EPS fell 5% and missed the roughly $0.98 consensus estimate. Read the two EPS lines side by side — $0.86 reported versus $0.99 base business — and the gap is mostly $129 million of restructuring charges, not weak selling.
Read the full analysis →Revenue$5.36BYoY +4.90%
EPS (non-GAAP)$0.99Beatest. $0.98
Next-day move−1.56%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-31 | $5.4B | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-05-01 | $5.3B | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-01-30 | $20.4B | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-31 | $5.1B | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-08-01 | $5.1B | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-25 | $4.9B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 84 of its 5-year rangeExpensive
5-year range 22.1 – 41.6 · Median 30.8
Last 4 quarters: $1.3B in buybacks + $0 in dividends, 1.74% of market cap combined
P/E (TTM)
38.1
P/B
—
P/S
3.7
Dividend Yield
2.48%
Earnings Reaction
Over the last 6 reports, the stock moved ±1.9% on average on the first trading day after, rising 1 times
Most recent −1.56%
Volatility & Correlation
1-year beta -0.17 · Correlation with S&P 500 -0.09Low beta
Annualized volatility 23% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 4 · $31.0MNet selling $31.0M
- 08-24Tsourapas PanagiotisCOO, CD, EMEA, APac, SkinSell$0.92M10,000 shares · Avg price 92.05
- 08-06CAHILL JOHN TDirectorSell$0.39M4,170 shares · Avg price 93.37
- 08-05Wallace Noel R.Chairman, President & CEOSell$14.9M161,021 shares · Avg price 92.52
- 08-04Wallace Noel R.Chairman, President & CEOSell$14.8M161,021 shares · Avg price 91.92
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q3 | 5.37 | +4.6% | 60.2% | 0.75 | 0.94 |
| FY2026 Q2 | 5.36 | +4.9% | 61.5% | 0.69 | 0.86 |
| FY2026 Q1 | 5.32 | +8.4% | 60.6% | 0.65 | 0.80 |
| FY2025 Q4 | 5.23 | +5.8% | 60.2% | -0.04 | -0.04 |
| FY2025 Q3 | 5.13 | +1.9% | 59.4% | 0.74 | 0.91 |
| FY2025 Q2 | 5.11 | +1.0% | 60.1% | 0.74 | 0.91 |
| FY2025 Q1 | 4.91 | −3.0% | 60.8% | 0.69 | 0.85 |
| FY2024 Q4 | 4.95 | −0.1% | 60.3% | 0.74 | 0.89 |
| FY2024 Q3 | 5.03 | +2.4% | 61.1% | 0.74 | 0.90 |
| FY2024 Q2 | 5.06 | +4.9% | 60.6% | 0.73 | 0.89 |
| FY2024 Q1 | 5.07 | +6.2% | 60.0% | 0.68 | 0.83 |
| FY2023 Q4 | 4.95 | +6.9% | 59.6% | 0.72 | 0.86 |